A prospective observational study using a wearable device to assess physical activity in early-stage breast cancer patients starting neoadjuvant chemotherapy.(TRACK-BC)
- Conditions
- Patients with early-stage breast cancer (Stage I-IIIA) scheduled to start neoadjuvant chemotherapy in an outpatient setting
- Registration Number
- JPRN-UMIN000053991
- Lead Sponsor
- Kansai Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Not provided
1) Patients who have received previous drug therapy for breast cancer. 2) Patients who may experience a significant decrease in physical activity measured by the wearable device, such as those who use a wheelchair. 3) Patients who are deemed by the investigators or others to be ineligible because of psychiatric disorders that may affect the evaluation to be conducted in this study. 4) Patients who are scheduled to be hospitalized during participation in the study. 5) Patients who are scheduled to travel abroad during participation in the study. 6) Pregnant patients or patients who plan to become pregnant during the study period. 7) Patients who are participating or will participate in a clinical trial involving an intervention. 8) Patients who are deemed inappropriate as research subjects by the investigators or others, regardless of the reason.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method